Forbes Under 30 alum Sajith Wickramasekara scores an $850 million valuation for his biotech R&D startup Benchling. Amid the coronavirus pandemic, the company is helping big biotech companies work on potential therapeutics and vaccines for Covid-19.
Category: /under30
Meet The MIT PhD Who Just Raised $65 Million For His Clinical Stage Cell Therapy Company
Armon Sharei’s SQZ Biotech announced it raised a $65 Million-Series D round, led by Temasek with participation from another new, US-based fund as well as additional participation from existing investors, including GV, Illumina Ventures, Invus, JDRF T1D…
Portuguese Tech Entrepreneurs Join Forces To Create Websites And Apps That Help In The Fight Against The Coronavirus
In mid-March, 60 Portuguese tech entrepreneurs started Tech4Covid19, a movement that has launched several public service apps and websites which help people in the country overcome the threats and challenges posed by the virus. Today, they are over 540…
8 Under 18: The Young Trailblazers Stepping Up During The Pandemic
Here are just a few of the many middle and high school-aged innovators leading coronavirus relief efforts across their local communities.
Meet The Nigerian Entrepreneurs Who Just Raised $10 Million To Transform Africa’s Healthcare
Helium Health, cofounded by Nigerian entrepreneurs and 2019 Forbes 30 Under 30 honorees Adegoke Olubusi, Tito Ovia, and Dimeji Sofowora, announced today that it has raised $10 million in Series A round, led by Global Ventures and Asia Africa Investment…
